Donna Rounds joined Hospital for Special Surgery (HSS) in February 2008 to lead their efforts in developing and commercializing orthopedic and rheumatology technologies. She brings with her a broad range of experience in business development, intellectual asset management, and technology transfer. Prior to joining HSS, she spent five years at Columbia University’s Science and Technology Ventures developing and commercializing healthcare related technologies, as well as championing start-up companies for her portfolio of scientists. Before Science and Technology Ventures, she was a business development executive at British Technology Group, BTG, plc, where she sourced, assessed and acquired early stage life and physical science technologies. She began her career in developing technology assets as one of the founders of Physiome Sciences, Inc. a biotechnology company that developed computational models of cells, tissues and organs. She holds a Ph.D. from Yale University in Molecular Biophysics and Biochemistry and an undergraduate degree from the University of California at Berkeley.